🚀 VC round data is live in beta, check it out!
BBS-Bioactive Bone Valuation Multiples
Discover revenue and EBITDA valuation multiples for BBS-Bioactive Bone and similar public comparables like Perpetua Medical, SensoDetect, Work Medical Technology Group, Profusa and more.
BBS-Bioactive Bone Overview
About BBS-Bioactive Bone
BBS-Bioactive Bone Substitutes PLC is a Finnish health technology company, that develops, designs and manufactures inventive bioactive bone-graft substitute implants. Its bioactive implants provide clinical and financial benefits for the treatment of patients with bone defects and healing problems.
Founded
2003
HQ
Employees
22
Website
Sectors
Financials (FY)
EV
$7M
BBS-Bioactive Bone Financials
BBS-Bioactive Bone reported last fiscal year revenue of — and negative EBITDA of ($4M).
In the same fiscal year, BBS-Bioactive Bone generated ($4K) in gross profit, ($4M) in EBITDA losses, and had net loss of ($4M).
BBS-Bioactive Bone P&L
In the most recent fiscal year, BBS-Bioactive Bone reported revenue of — and EBITDA of ($4M).
BBS-Bioactive Bone expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Gross Profit | — | XXX | ($4K) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($4M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($4M) | XXX | XXX | XXX |
| Net Debt | — | — | $3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BBS-Bioactive Bone Stock Performance
BBS-Bioactive Bone has current market cap of $2M, and enterprise value of $7M.
Market Cap Evolution
BBS-Bioactive Bone's stock price is $0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $2M | 0.3% | XXX | XXX | XXX | $-0.14 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBBS-Bioactive Bone Valuation Multiples
BBS-Bioactive Bone trades at (2.0x) EV/EBITDA.
BBS-Bioactive Bone Financial Valuation Multiples
As of April 8, 2026, BBS-Bioactive Bone has market cap of $2M and EV of $7M.
Equity research analysts estimate BBS-Bioactive Bone's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BBS-Bioactive Bone has a P/E ratio of (0.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (2.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (1.9x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (1722.2x) | XXX | XXX | XXX |
| P/E | — | XXX | (0.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BBS-Bioactive Bone Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BBS-Bioactive Bone Margins & Growth Rates
BBS-Bioactive Bone's revenue in the last fiscal year grew by —.
BBS-Bioactive Bone's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
BBS-Bioactive Bone Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BBS-Bioactive Bone Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Perpetua Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| SensoDetect | XXX | XXX | XXX | XXX | XXX | XXX |
| Work Medical Technology Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Profusa | XXX | XXX | XXX | XXX | XXX | XXX |
| Nuwellis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BBS-Bioactive Bone M&A Activity
BBS-Bioactive Bone acquired XXX companies to date.
Last acquisition by BBS-Bioactive Bone was on XXXXXXXX, XXXXX. BBS-Bioactive Bone acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BBS-Bioactive Bone
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBBS-Bioactive Bone Investment Activity
BBS-Bioactive Bone invested in XXX companies to date.
BBS-Bioactive Bone made its latest investment on XXXXXXXX, XXXXX. BBS-Bioactive Bone invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BBS-Bioactive Bone
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BBS-Bioactive Bone
| When was BBS-Bioactive Bone founded? | BBS-Bioactive Bone was founded in 2003. |
| Where is BBS-Bioactive Bone headquartered? | BBS-Bioactive Bone is headquartered in Finland. |
| How many employees does BBS-Bioactive Bone have? | As of today, BBS-Bioactive Bone has over 22 employees. |
| Is BBS-Bioactive Bone publicly listed? | Yes, BBS-Bioactive Bone is a public company listed on Nasdaq Helsinki. |
| What is the stock symbol of BBS-Bioactive Bone? | BBS-Bioactive Bone trades under BONEH ticker. |
| When did BBS-Bioactive Bone go public? | BBS-Bioactive Bone went public in 2018. |
| Who are competitors of BBS-Bioactive Bone? | BBS-Bioactive Bone main competitors are Perpetua Medical, SensoDetect, Work Medical Technology Group, Profusa. |
| What is the current market cap of BBS-Bioactive Bone? | BBS-Bioactive Bone's current market cap is $2M. |
| Is BBS-Bioactive Bone profitable? | No, BBS-Bioactive Bone is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.